Papers
8
Total Citations
45
H-Index
5
About
Dr. Chung-Hsin Chen is a leading urologic oncologist whose research focuses on improving risk stratification and treatment outcomes for prostate cancer, particularly in high-risk and locally advanced disease. His major contributions include pioneering the use of the Prostate Health Index (PHI) and %p2PSA to predict aggressive pathological outcomes before radical prostatectomy, work that has garnered significant attention (9 citations). He has also critically examined the paradoxical relationship between low initial PSA levels and more rapid disease progression in high-grade prostate cancer (8 citations), challenging conventional clinical assumptions. Through propensity score matching, Dr. Chen has provided valuable comparative data on robotic-assisted laparoscopic radical prostatectomy versus radiotherapy with androgen deprivation therapy for locally advanced disease (7 citations). His investigations into the role of NKG2A and circulating extracellular vesicles as regulators of natural killer cell activity after prostatectomy (6 citations) represent a novel translational direction. Notably, his work demonstrates that laparoscopic radical prostatectomy monotherapy can be oncologically effective in selected high-risk patients with only one D’Amico risk factor (6 citations). Dr. Chen’s research consistently integrates surgical innovation with molecular insights, advancing personalized care in prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8